Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Shivani Atri Singh M.B.B.S., M.S., M.Ch., D.N.B 198, Hargobind Enclave, Near Gauri Shankar Mandir, Opp
Findings presented at the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit in Montreal in April indicate that GLP-1 medications containing tirzepatide (Mounjaro and Zepbound) may help lower the risk of heart problems in people with obesity undergoing certain heart procedures
The outcome will be reiterated over a period of time based on your dosage and frequency of treatment
10.1161/CIRCHEARTFAILURE.114.001564 225 WankS
4.3 Epilepsy and uremia 4.3.1 Association of uremia with seizures Patients with end-stage renal disease who underwent dialysis had a greater prevalence of epilepsy (8.8%), and the risk of death in patients diagnosed with epilepsy was 1.11 times greater than that in patients without epilepsy (108)
We are not responsible for incorrect or outdated descriptions and/or images
